|
CGRRF1 expression based on
|
KIRP : Kidney renal papillary cell carcinoma
| Comparison | Statistical significance |
| Normal-vs-Primary | 1.65500946280872E-12 |
|
KIRP : Kidney renal papillary cell carcinoma Note
Cancer stage information is not available for 89 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
6.66979804719858E-11 |
| Normal-vs-Stage2 |
1.63380420303838E-11 |
| Normal-vs-Stage3 |
1.65299995913415E-09 |
| Normal-vs-Stage4 |
4.00559999946815E-07 |
| Stage1-vs-Stage2 |
3.412200E-02 |
| Stage1-vs-Stage3 |
3.120200E-01 |
| Stage1-vs-Stage4 |
2.601600E-01 |
| Stage2-vs-Stage3 |
5.626800E-01 |
| Stage2-vs-Stage4 |
8.896200E-01 |
| Stage3-vs-Stage4 |
6.160400E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient race information is not available for 15 samples and two samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
1.87028170728354E-12 |
| Normal-vs-AfricanAmerican |
1.53669998947947E-09 |
| Normal-vs-Asian |
5.806700E-04 |
| Caucasian-vs-AfricanAmerican |
3.978200E-01 |
| Caucasian-vs-Asian |
8.992200E-01 |
| AfricanAmerican-vs-Asian |
6.651800E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
1.63136171238421E-12 |
| Normal-vs-Female |
7.22269999364755E-09 |
| Male-vs-Female |
3.169400E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient BMI information is not available for 72 samples.
| Descriptions |
| Normal weight |
BMI greater than equal to 18.5 and BMI less than 25 |
Extereme weight |
BMI greater than equal to 25 and BMI less than 30 |
| Obese |
BMI greater than equal to 30 and BMI less than 40 |
Extreme Obese |
BMI greater than 40 |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Normal_Weight |
1.91310000063893E-08 |
| Normal-vs-Extreme_Weight |
1.36060052113862E-10 |
| Normal-vs-Obese |
1.11609610442542E-11 |
| Normal-vs-Extreme_Obese |
5.95789999999763E-05 |
| Normal_Weight-vs-Extreme_Weight |
7.464400E-01 |
| Normal_Weight-vs-Obese |
7.863800E-01 |
| Normal_Weight-vs-Extreme_Obese |
9.013200E-01 |
| Extreme_Weight-vs-Obese |
9.558000E-01 |
| Extreme_Weight-vs-Extreme_Obese |
9.607200E-01 |
| Obese-vs-Extreme_Obese |
9.795200E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient age information is not available for 3 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
3.22949999997935E-06 |
| Normal-vs-Age(41-60Yrs) |
8.37319991120467E-10 |
| Normal-vs-Age(61-80Yrs) |
1.13242748511766E-14 |
| Normal-vs-Age(81-100Yrs) |
1.7484000000012E-06 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
8.292000E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
3.743200E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
3.676200E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
2.450500E-02 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
2.165400E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
7.404200E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma NOTE
Histology information is not available for 17 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-VS-Type1 PRCC |
8.73168204407193E-12 |
| Normal-VS-Type2 PRCC |
1.69331215715829E-12 |
| Normal-VS-KIRP CIMP |
7.26909999970715E-07 |
| Normal-VS-Unclassified PRCC |
3.88679999296926E-09 |
| Type1 PRCC-VS-Type2 PRCC |
2.475900E-02 |
| Type1 PRCC-VS-KIRP CIMP |
7.958200E-02 |
| Type1 PRCC-VS-Unclassified PRCC |
1.361240E-01 |
| Type2 PRCC-VS-KIRP CIMP |
4.811800E-01 |
| Type2 PRCC-VS-Unclassified PRCC |
8.487400E-01 |
| KIRP CIMP-VS-Unclassified PRCC |
4.546000E-01 |
|
Histologic PRCC subtypes: Ricketts CJ et al, The Cancer Genome Atlas Comprehensive Molecular Characterization of Renal Cell Carcinoma. Cell Rep. 2018 Apr 3;23(1):313-326.e5. doi: 10.1016/j.celrep.2018.03.075
|
KIRP : Kidney renal papillary cell carcinoma Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 211 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
6.66133814775094E-15 |
| Normal-vs-N1 |
1.20709999773538E-08 |
| Normal-vs-N2 |
9.33439999961649E-07 |
| N0-vs-N1 |
3.887000E-01 |
| N0-vs-N2 |
1.975580E-02 |
| N1-vs-N2 |
2.160100E-02 |
|
|
